Showing 25 to 36 of 90 results
Jessie J Announces Breast Cancer Diagnosis, Urges Early Detection
Pop star Jessie J, 37, revealed her early-stage breast cancer diagnosis, announcing upcoming surgery after a June 15th London performance; she shared the news to encourage openness and early detection.
Jessie J Announces Breast Cancer Diagnosis, Urges Early Detection
Pop star Jessie J, 37, revealed her early-stage breast cancer diagnosis, announcing upcoming surgery after a June 15th London performance; she shared the news to encourage openness and early detection.
Progress
44% Bias Score
Wales Rolls Out Cancer Drug Doubling Survival Time
The NHS in Wales now provides capivasertib, a new breast cancer drug shown to double life expectancy for half of women with oestrogen-fueled breast cancer when combined with hormone therapy; developed by Velindre Cancer Centre and Cardiff University, it's a significant advancement offering extended ...
Wales Rolls Out Cancer Drug Doubling Survival Time
The NHS in Wales now provides capivasertib, a new breast cancer drug shown to double life expectancy for half of women with oestrogen-fueled breast cancer when combined with hormone therapy; developed by Velindre Cancer Centre and Cardiff University, it's a significant advancement offering extended ...
Progress
56% Bias Score
New Drug Shows Significant Promise in Reducing Breast Cancer Progression
A clinical trial shows that the drug camizestrant reduces breast cancer progression by 52% compared to standard treatments, offering a potential breakthrough in precision medicine by using blood tests to detect treatment resistance early.
New Drug Shows Significant Promise in Reducing Breast Cancer Progression
A clinical trial shows that the drug camizestrant reduces breast cancer progression by 52% compared to standard treatments, offering a potential breakthrough in precision medicine by using blood tests to detect treatment resistance early.
Progress
48% Bias Score
Rapid MRI and Contrast Mammograms Significantly Improve Breast Cancer Detection in Women with Dense Breasts
Two studies published in The Lancet and Radiology demonstrate that mammograms with contrast agents and 10-minute MRI are three times more effective than ultrasounds in detecting breast cancer in women with dense breasts and negative mammograms, impacting early diagnosis and treatment.
Rapid MRI and Contrast Mammograms Significantly Improve Breast Cancer Detection in Women with Dense Breasts
Two studies published in The Lancet and Radiology demonstrate that mammograms with contrast agents and 10-minute MRI are three times more effective than ultrasounds in detecting breast cancer in women with dense breasts and negative mammograms, impacting early diagnosis and treatment.
Progress
36% Bias Score
Alcohol Consumption Linked to Increased Breast Cancer Risk in Women
Corrine Barraclough's breast cancer diagnosis at 48 highlights research linking alcohol to the disease, particularly in premenopausal women; studies show alcohol is a leading modifiable risk factor, with no safe consumption level, impacting 12.6% of premenopausal cases in Australia.
Alcohol Consumption Linked to Increased Breast Cancer Risk in Women
Corrine Barraclough's breast cancer diagnosis at 48 highlights research linking alcohol to the disease, particularly in premenopausal women; studies show alcohol is a leading modifiable risk factor, with no safe consumption level, impacting 12.6% of premenopausal cases in Australia.
Progress
60% Bias Score
Olaparib Improves Survival Rates for Inherited Breast Cancer
A UK trial found that giving olaparib before surgery to women with early-stage BRCA1 or BRCA2 mutated breast cancer led to 100% survival at 36 months in the treatment group, compared to a 89% survival rate in the control group, potentially benefiting over 1,200 UK women annually.
Olaparib Improves Survival Rates for Inherited Breast Cancer
A UK trial found that giving olaparib before surgery to women with early-stage BRCA1 or BRCA2 mutated breast cancer led to 100% survival at 36 months in the treatment group, compared to a 89% survival rate in the control group, potentially benefiting over 1,200 UK women annually.
Progress
48% Bias Score
New 'Smart Bomb' Cancer Treatment Shows Significant Improvement in HER2-Positive Metastatic Breast Cancer
A clinical trial involving nearly 400 patients with HER2-positive metastatic breast cancer showed that a new treatment combining T-DXd and pertuzumab reduced disease progression or death risk by 44%, with 15% achieving complete remission, compared to 8.5% with standard therapy; the findings will be ...
New 'Smart Bomb' Cancer Treatment Shows Significant Improvement in HER2-Positive Metastatic Breast Cancer
A clinical trial involving nearly 400 patients with HER2-positive metastatic breast cancer showed that a new treatment combining T-DXd and pertuzumab reduced disease progression or death risk by 44%, with 15% achieving complete remission, compared to 8.5% with standard therapy; the findings will be ...
Progress
48% Bias Score
Camizestrant Shows Significant Promise in Treating Aggressive Breast Cancer
A clinical trial shows that the drug camizestrant significantly reduces the risk of progression or death in patients with HR-positive HER2-negative breast cancer who have the ESR1 mutation, a common cause of treatment resistance; the drug is being fast-tracked for approval in the US and UK.
Camizestrant Shows Significant Promise in Treating Aggressive Breast Cancer
A clinical trial shows that the drug camizestrant significantly reduces the risk of progression or death in patients with HR-positive HER2-negative breast cancer who have the ESR1 mutation, a common cause of treatment resistance; the drug is being fast-tracked for approval in the US and UK.
Progress
56% Bias Score
Actress Kara Tointon Has Preventative Double Mastectomy After BRCA Gene Test
Former EastEnders actress Kara Tointon, 41, underwent a double mastectomy and preventative ovarian surgery after discovering she carries the BRCA gene, which significantly increases breast and ovarian cancer risk, following her mother's death from ovarian cancer in 2019.
Actress Kara Tointon Has Preventative Double Mastectomy After BRCA Gene Test
Former EastEnders actress Kara Tointon, 41, underwent a double mastectomy and preventative ovarian surgery after discovering she carries the BRCA gene, which significantly increases breast and ovarian cancer risk, following her mother's death from ovarian cancer in 2019.
Progress
44% Bias Score
Improved Breast Screening Could Save Hundreds of UK Lives
A UK study suggests that adding contrast-enhanced mammography or abbreviated MRI to breast screening could identify 3,500 extra cancers yearly, saving 700 lives, by detecting cancers hidden in dense breast tissue, a factor affecting 10% of women.
Improved Breast Screening Could Save Hundreds of UK Lives
A UK study suggests that adding contrast-enhanced mammography or abbreviated MRI to breast screening could identify 3,500 extra cancers yearly, saving 700 lives, by detecting cancers hidden in dense breast tissue, a factor affecting 10% of women.
Progress
48% Bias Score
Kat Timpf Returns to TV After Breast Cancer Surgery
Fox News host Kat Timpf, 36, returned to television after a double mastectomy for stage zero breast cancer, diagnosed just before giving birth to her son in February; she joked about her surgery on Fox Nation's "What Did I Miss," receiving positive viewer response.
Kat Timpf Returns to TV After Breast Cancer Surgery
Fox News host Kat Timpf, 36, returned to television after a double mastectomy for stage zero breast cancer, diagnosed just before giving birth to her son in February; she joked about her surgery on Fox Nation's "What Did I Miss," receiving positive viewer response.
Progress
48% Bias Score
Cancer Diagnoses Surge Among Young Dutch Adults
A new report from the Integraal Kankercentrum Nederland (IKNL) reveals a significant increase in cancer diagnoses among young adults (18-39) in the Netherlands, with women being diagnosed 1.5 times more often than men; the most common cancers for young women are breast, cervical and melanoma, while ...
Cancer Diagnoses Surge Among Young Dutch Adults
A new report from the Integraal Kankercentrum Nederland (IKNL) reveals a significant increase in cancer diagnoses among young adults (18-39) in the Netherlands, with women being diagnosed 1.5 times more often than men; the most common cancers for young women are breast, cervical and melanoma, while ...
Progress
24% Bias Score
Showing 25 to 36 of 90 results